IL1F10 and rheumatoid arthritis: Supporting this hypothesis, IL-38 levels are significantly higher in RA patients who test positive for anti-cyclic citrullinated peptide (anti-CCP) antibodies compared to seronegative individuals, aligning with the established diagnostic and prognostic value of anti-CCP (43, 44).